[1] |
张若梅, 刘先勇. 糖皮质激素在重度慢性乙型病毒性肝炎治疗中的应用[J]. 医药导报, 2020,39(2):199-201.
|
[2] |
TERRAULT N A, LOK A S F, MCMAHON B J, et al. Update on prevention,diagnosis,and treatment of chronic hepatitis B:AASLD 2018 hepatitis B guidance[J]. Hepatology, 2018,67(4):1560-1599.
DOI
URL
|
[3] |
张丽翠, 钟晨, 张砚, 等. 恩替卡韦治疗慢性乙型病毒性肝炎患者的临床研究[J]. 中国临床药理学杂志, 2019,35(20):2539-2542.
|
[4] |
BERTOLETTIA , LE BERT N. Immunotherapy for chronic hepatitis B virus infection[J]. Gut Liver, 2018,12(5):497-507.
DOI
URL
|
[5] |
王烈, 胡义忠, 徐秀亮, 等. 血清sP-selectin、sICAM-1和免疫球蛋白检测对乙肝肝硬化预后评估的意义[J]. 中国免疫学杂志, 2017,33(11):1699-1705.
|
[6] |
中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 中华肝脏病杂志, 2019,27(12):938-961.
|
[7] |
MERLE N S, GRUNENWOLD A, RAJARATNAM H, et al. Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles[J]. JCI Insight, 2018,3(12):e96910.
DOI
URL
|
[8] |
IANNACONE M. Platelet-mediated modulation of adaptive immunity[J]. Semin Immunol, 2016,28(6):555-560.
DOI
URL
|
[9] |
BHAT A, DAS S, YADAV G, et al. Hyperoxidized albumin modulates platelets and promotes inflammation through CD36 receptor in severe alcoholic hepatitis[J]. Hepatol Commun, 2019,4(1):50-65.
DOI
URL
|
[10] |
ALI R O, MOON M S, TOWNSED E C, et al. Exploring the link between platelet numbers and vascular homeostasis across early and late stages of fibrosis in hepatitis C[J]. Dig Dis Sci, 2020,65(2):524-533.
DOI
URL
|
[11] |
ZHANG H, ZHANG S, ZHANG J, et al. Improvement of human platelet aggregation post-splenectomy with paraesophagogastric devascularization in chronic hepatitis B patients with cirrhotic hypersplenism[J]. Platelets, 2020,31(8):1019-1027.
DOI
URL
|
[12] |
TANA M M, ZHAO X, BRADSHAW A, et al. Factors associated with the platelet count in patients with chronic hepatitis C[J]. Thromb Res, 2015,135(5):823-828.
DOI
URL
|
[13] |
杨斌, 张海泉, 于鲜君, 等. 细胞间黏附分子-1在肝癌组织中表达及临床意义[J]. 临床军医杂志, 2019,47(9):920-922.
|
[14] |
陈曦, 胡冬, 吴丹, 等. 慢性乙肝患者血清可溶性黏附分子P-selectin、ICAM-1与病情变化的相关性研究[J]. 海南医学院学报, 2018,24(24):2153-2157.
|
[15] |
ELSHEREDY A G, ALMAEEN A H, GHAZY A A, et al. Impact of interleukin 28B and ICAM-1 genetic polymorphisms on response to direct antiviral treatment among HCV infected patients[J]. Endocr Metab Immune Disord Drug Targets, 2020,20(8):1328-1335.
DOI
URL
|
[16] |
CASTELLI G, PELOSI E, TESTA U. Liver cancer:molecular characterization,clonal evolution and cancer stem cells[J]. Cancers(Basel), 2017,9(9):127.
|
[17] |
操伟庆, 季榕. 慢性乙型肝炎患者血清中IL-17A和TGF-β1水平的变化及意义[J]. 贵州医科大学学报, 2017,42(12):1431-1435.
|
[18] |
王凌旭. T细胞17与IL-17在慢性乙肝患者血清中的表达意义[J]. 医药论坛杂志, 2016,37(9):83-84.
|